Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

Clinical trial NCT00621764 · COMPLETED

Trial details

NCT number: NCT00621764
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Japanese Encephalitis Hepatitis A

Start date: 2008-03-01
Primary completion: 2009-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.